Skip to content

Skin autofluorescence and surgical failure in retinal detachment patients

The role of skin autofluorescence as a predictor for post-operative proliferative vitreoretinopathy and surgical failure in patients with retinal detachment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27827
Enrollment
500
Registered
2013-11-27
Start date
2013-11-11
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhegmatogenous retinal detachment (RRD) is a sight-threatening condition, most often initiated by a posterior vitreous detachment-associated retinal tear. A recent study found an incidence of RRD in the Netherlands of 18.2 per 100,000 people.

Interventions

None

Sponsors

University Medical Center Groningen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Willingness to participate. 2. Patients, newly diagnosed with retinal detachment, scheduled for vitrectomy. 3. Age: >18 years.

Exclusion criteria

Exclusion criteria: 1. Dark coloured skin that impairs the reliability of the autofluorescence measurement. 2. Skin abnormalities on both arms that will impair the reliability of the autofluorescence measurement. 3. Local or general active infection or inflammatory disease. 4. Known renal disease with impairment of renal function class CKD ≥3 (≤ 60 ml/min according to eGFR), current dialysis treatment, or a history of renal transplantation.

Design outcomes

Primary

MeasureTime frame
1. Surgical failure

Secondary

MeasureTime frame
2. Skin autofluorescence 3. Vitreous body AGE levels 4. Vitreous body sRAGE levels 5. plasma sRAGE levels 6. Glyoxalase polymorphisms 7. RAGE polymorphisms 8. Age, 9. gender, 10. surface area of retinal detachment, 11. number of retinal defects, 12. macular detachment, 13. detachment duration, 14. pre-operative PVR grade, 15. presence of diabetes, 16. pseudophakia, 17. intraoperative use of gas or silicon oil, 18. intraoperative cryotherapy, intraoperative minor hemorrhage.

Contacts

Public ContactL.I. Los

University Medical Center Groningen (UMCG), Department of Ophthalmology P.O. Box 30.001

l.i.los@ohk.umcg.nl+31 (0)50 3612510

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)